A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
for Dravet Syndrome
Drug: zorevunersen
31 locations incl. Phoenix
Sponsor: Stoke Therapeutics, Inc
Sex: All·Age: 2 - 17
Code: NCT06872125·Phase 3·Recruiting